What is the current Price Target for the Pharvaris NV stock?

The average Pharvaris NV target price is $46.92. This is 47.04% higher than the current stock price. The highest price target is 146.79%, the lowest is 20.28%. 17 Analysts have issued a price target Pharvaris NV 2027 .

How high will the Pharvaris NV stock rise?

No reliable answer can be given as to how high the Pharvaris NV stock will rise. The performance of stocks, including the Pharvaris NV stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Pharvaris NV stock today?

The performance of Pharvaris NV stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Pharvaris NV stock fall?

The decline in Pharvaris NV stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Pharvaris NV Forecast, price target & analysts

$31.70

0.66%

Nasdaq, Sep 29, 10:47 am EDT. Market open.

ISIN

NL00150005Y4

Symbol

PHVS

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Analysts Charts Ownership News Strategies

Pharvaris NV Target price 2026 - Analyst rating & recommendation

Pharvaris NV Classifications & Recommendation

Buy

90%

Hold

10%

Pharvaris NV Price Target

Target Price	$46.92
Price	$31.91
Potential	47.04% register free of charge
Number of Estimates	17

	17 Analysts have issued a price target Pharvaris NV 2027 . The average Pharvaris NV target price is $46.92. This is 47.04% register free of charge higher than the current stock price. The highest price target is $78.75 146.79% register free of charge , the lowest is $38.38 20.28% register free of charge .
	A rating was issued by 21 analysts: 19 Analysts recommend Pharvaris NV to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Pharvaris NV stock has an average upside potential 2027 of 47.04% register free of charge . Most analysts recommend the Pharvaris NV stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-3.38	-3.25
	19.86%	3.85%
P/E		negative

15 Analysts have issued a Pharvaris NV forecast for earnings per share. The average Pharvaris NV EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-3.38	19.86%
2026	$-3.25 3.85% unlock
2027	$-3.02 7.08% unlock
2028	$-1.17 61.26% unlock
2029	$1.40 219.66% unlock
2030	$4.53 223.57% unlock
2031	$7.26 60.26% unlock
2032	$9.84 35.54% unlock
2033	$10.76 9.35% unlock

Current	-11.20	67.73%
2026	-9.80 12.47% unlock
2027	-10.58 7.96% unlock
2028	-27.25 157.56% unlock
2029	22.75 183.49% unlock
2030	7.04 69.05% unlock
2031	4.40 37.50% unlock
2032	3.24 26.36% unlock
2033	2.97 8.33% unlock

Pharvaris NV...

Current Pharvaris NV Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Sep 10 2026
RBC Capital	Locked ➜ Locked	Locked	Sep 09 2026
Leerink Partners	Locked ➜ Locked	Locked	Sep 09 2026
Morgan Stanley	Locked ➜ Locked	Locked	Sep 09 2026
Wedbush	Locked ➜ Locked	Locked	Sep 09 2026
Citizens	Locked ➜ Locked	Locked	Sep 09 2026
Wells Fargo	Locked ➜ Locked	Locked	Sep 09 2026

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Sep 10 2026
Locked RBC Capital: Locked ➜ Locked	Sep 09 2026
Locked Leerink Partners: Locked ➜ Locked	Sep 09 2026
Locked Morgan Stanley: Locked ➜ Locked	Sep 09 2026
Locked Wedbush: Locked ➜ Locked	Sep 09 2026
Locked Citizens: Locked ➜ Locked	Sep 09 2026
Locked Wells Fargo: Locked ➜ Locked	Sep 09 2026

Discover more stocks with a high price target

NIO ADR 104.00%

Alibaba Group Holding Ltd 73.67%

Rheinmetall 68.89%

Infineon 63.18%

Tencent Holdings Ltd. 58.19%

Adyen 55.40%

TUI 52.20%

BYD 51.64%

Uber Technologies 51.14%

Siemens Energy 48.42%

Adidas 41.08%

Netflix 39.97%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now